Variations in the colchicine-binding domain provide insight into the structural switch of tubulin

Structural changes occur in the αβ-tubulin heterodimer during the microtubule assembly/disassembly cycle. Their most prominent feature is a transition from a straight, microtubular structure to a curved structure. There is a broad range of small molecule compounds that disturbs the microtubule cycle, a class of which targets the colchicine-binding site and prevents microtubule assembly. This class includes compounds with very different chemical structures, and it is presently unknown whether they prevent tubulin polymerization by the same mechanism. To address this issue, we have determined the structures of tubulin complexed with a set of such ligands and show that they interfere with several of the movements of tubulin subunits structural elements upon its transition from curved to straight. We also determined the structure of tubulin unliganded at the colchicine site; this reveals that a β-tubulin loop (termed T7) flips into this site. As with colchicine site ligands, this prevents a helix which is at the interface with α-tubulin from stacking onto a β-tubulin β sheet as in straight protofilaments. Whereas in the presence of these ligands the interference with microtubule assembly gets frozen, by flipping in and out the β-subunit T7 loop participates in a reversible way in the resistance to straightening that opposes microtubule assembly. Our results suggest that it thereby contributes to microtubule dynamic instability.

[1]  E. Nogales,et al.  High-Resolution Model of the Microtubule , 1999, Cell.

[2]  Z. Otwinowski,et al.  Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[3]  P. Curmi,et al.  Stathmin Family Proteins Display Specific Molecular and Tubulin Binding Properties* , 2001, The Journal of Biological Chemistry.

[4]  T. Nagasu,et al.  Novel sulfonamides as potential, systemically active antitumor agents. , 1992, Journal of medicinal chemistry.

[5]  Kenneth H. Downing,et al.  Refined structure of αβ-tubulin at 3.5 Å resolution 1 1Edited by I. A. Wilson , 2001 .

[6]  Marcel Knossow,et al.  Insight into the GTPase activity of tubulin from complexes with stathmin-like domains. , 2007, Biochemistry.

[7]  S. Martin,et al.  Phosphate release during microtubule assembly: what stabilizes growing microtubules? , 1999, Biochemistry.

[8]  S. N. Timasheff,et al.  Effect of colchicine analogues on the dissociation of alpha beta tubulin into subunits: the locus of colchicine binding. , 1994, Biochemistry.

[9]  J. Jaén,et al.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[10]  G. Hutchins,et al.  Synthesis, biodistribution and micro-PET imaging of radiolabeled antimitotic agent T138067 analogues. , 2004, Bioorganic & medicinal chemistry letters.

[11]  G N Murshudov,et al.  Use of TLS parameters to model anisotropic displacements in macromolecular refinement. , 2001, Acta crystallographica. Section D, Biological crystallography.

[12]  E. Nogales,et al.  Refined structure of alpha beta-tubulin at 3.5 A resolution. , 2001, Journal of molecular biology.

[13]  E A Merritt,et al.  Raster3D: photorealistic molecular graphics. , 1997, Methods in enzymology.

[14]  D. Agard,et al.  The lattice as allosteric effector: Structural studies of αβ- and γ-tubulin clarify the role of GTP in microtubule assembly , 2008, Proceedings of the National Academy of Sciences.

[15]  P. Curmi,et al.  The 4 Å X-Ray Structure of a Tubulin:Stathmin-like Domain Complex , 2000, Cell.

[16]  Patrick A. Curmi,et al.  Insight into tubulin regulation from a complex with colchicine and a stathmin-like domain , 2004, Nature.

[17]  Collaborative Computational,et al.  The CCP4 suite: programs for protein crystallography. , 1994, Acta crystallographica. Section D, Biological crystallography.

[18]  T. Arai.  Inhibition of microtubule assembly in vitro by TN‐16, a synthetic antitumor drug , 1983, FEBS letters.

[19]  J. Zou,et al.  Improved methods for building protein models in electron density maps and the location of errors in these models. , 1991, Acta crystallographica. Section A, Foundations of crystallography.

[20]  Wolfgang Kabsch,et al.  Automatic processing of rotation diffraction data from crystals of initially unknown symmetry and cell constants , 1993 .

[21]  Ki Young Lee,et al.  Design and biological evaluation of novel tubulin inhibitors as antimitotic agents using a pharmacophore binding model with tubulin. , 2006, Journal of medicinal chemistry.

[22]  K. A. Wall,et al.  A monoclonal antibody against the type II isotype of beta-tubulin. Preparation of isotypically altered tubulin. , 1988, The Journal of biological chemistry.

[23]  J. Mozziconacci,et al.  Tubulin Dimers Oligomerize before Their Incorporation into Microtubules , 2008, PloS one.

[24]  M. Castoldi,et al.  Purification of brain tubulin through two cycles of polymerization-depolymerization in a high-molarity buffer. , 2003, Protein expression and purification.

[25]  G. Gordon,et al.  A Phase II Study of ABT-751 in Patients with Advanced Non-small Cell Lung Cancer , 2008, Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer.

[26]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[27]  S. Martin,et al.  Response of microtubules to the addition of colchicine and tubulin-colchicine: evaluation of models for the interaction of drugs with microtubules. , 1997, The Biochemical journal.

[28]  P. Kraulis.  A program to produce both detailed and schematic plots of protein structures , 1991 .

[29]  William V Nicholson,et al.  Microtubule structure at 8 A resolution. , 2002, Structure.

[30]  J. Correia,et al.  Mg2+ dependence of guanine nucleotide binding to tubulin. , 1987, The Journal of biological chemistry.

[31]  M. Kirschner,et al.  Dynamic instability of microtubule growth , 1984, Nature.

[32]  Raimond B G Ravelli,et al.  Structural insight into the inhibition of tubulin by vinca domain peptide ligands , 2008, EMBO reports.

[33]  A. W. Schüttelkopf,et al.  PRODRG: a tool for high-throughput crystallography of protein-ligand complexes. , 2004, Acta crystallographica. Section D, Biological crystallography.

[34]  K. Balakin,et al.  Recent progress in discovery and development of antimitotic agents. , 2007, Anti-cancer agents in medicinal chemistry.

[35]  R M Esnouf,et al.  An extensively modified version of MolScript that includes greatly enhanced coloring capabilities. , 1997, Journal of molecular graphics & modelling.

[36]  J. Díaz,et al.  Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition. , 1993, Biochemistry.

[37]  A. Yamaguchi,et al.  Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin. , 1997, Cancer research.

[38]  Y. Engelborghs,et al.  General features of the recognition by tubulin of colchicine and related compounds , 1998, European Biophysics Journal.

[39]  Zbigniew Dauter,et al.  A common protein fold and similar active site in two distinct families of β-glycanases , 1996, Nature Structural Biology.